missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Tocris Bioscience™ RIPGBM

Click to view available options
Quantity:
10 mg
50 mg
Unit Size:
10mg
50mg
Description
RIPGBM is a RIPK2 modulator, pro-drug of cRIPGM. cRIPGM binds RIPK2 (apparent Kd = 2.3 μM). Selectively induces apoptosis in glioblastoma multiforme cancer stem cell lines (EC50 is <500 nM). Five-fold selective for CSCs compared with control cell types. Reduces the formation of a prosurvival RIPK2/ TAK1 complex and increases the formation of a proapoptotic RIPK2/caspase 1 complex. Inhibits tumor formation and growth in vivo. Orally bioavailable and brain penetrant.
Specifications
Specifications
| Chemical Name or Material | N-[1,4-Dihydro-1,4-dioxo-3-[(phenylmethyl)amino]-2-naphthalenyl]-N-[(4-fluorophenyl)methyl]acetamide |
| CAS | 355406-76-7 |
| Quantity | 10 mg |
| Target | RIP Kinase Inhibitors |
| Molecular Formula | C26H21FN2O3 |
| Formula Weight | 1818 |
| Purity | 98% |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction